Author details

Full Name

Atsushi Umemura

Affiliation

ORCID

Career Start Year

1981

Papers

169

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37499354	Three-dimensional gait analysis of the effect of directional steering on gait in patients with Parkinson's disease.		2023
37034086	Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature.		2023
36830722	Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?		2023
37206478	Editorial: Impacts of drug-induced oxidative stress.		2023
36936495	Role of the subthalamic nucleus in perceiving and estimating the passage of time.		2023
36542263	Fibro-Scope V1.0.1: an artificial intelligence/neural network system for staging of nonalcoholic steatohepatitis.		2023
36854884	Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease.		2023
35137566	White matter microstructures in Parkinson's disease with and without impulse control behaviors.	Annals of Clinical and Translational Neurology	2022
35453652	Potential Therapeutic Targets and Promising Agents for Combating NAFLD.	Biomedicines	2022
35380992	Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis.	J Clin Invest	2022
35939571	Serum levels of immunoglobulin M-free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.	Hepatology Research	2022
35992727	Short-Term Motor Outcomes in Parkinson's Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study.	Parkinson's Disease	2022
36619644	Bortezomib is an effective enhancer for chemical probe-dependent superoxide detection.		2022
35322078	Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.	Scientific Reports	2022
34732847	Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.	Laboratory Investigation	2022
35031857	Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.		2022
34435630	TUBB3 E410K Syndrome With Childhood-Onset Nonalcoholic Steatohepatitis.	Journal of Clinical Endocrinology and Metabolism	2022
35287025	Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.	Mult Scler Relat Disord	2022
34483867	Case Report: Chronic Adaptive Deep Brain Stimulation Personalizing Therapy Based on Parkinsonian State.	Frontiers in Human Neuroscience	2021
33494064	[Management of Spinal Disorders in Parkinson's Disease].	Neurological Surgery	2021
33806040	Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor-MIG6 Axis.	Cancers	2021
34124830	Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis.	Hepatology Research	2021
33717266	SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3Î² signaling pathway in esophageal squamous cell carcinoma.	Oncology Letters	2021
33556765	Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.	Parkinsonism and Related Disorders	2021
33922278	The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease.	Genes	2021
34325387	White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.	Parkinsonism and Related Disorders	2021
33594747	Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.	Hepatology Research	2021
32867552	Early-start delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial.	Expert Opinion on Pharmacotherapy	2021
33350036	A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.	Hepatology Research	2021
34796113	Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress.	Frontiers in Oncology	2021
34458148	Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNÎ³/STAT1 Signaling in Hepatocellular Carcinoma Cells.	Frontiers in Oncology	2021
34716335	White matter and nigral alterations in multiple system atrophy-parkinsonian type.	npj Parkinson's Disease	2021
34948151	Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-Î²1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.	International Journal of Molecular Sciences	2021
33057432	The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.	PLoS ONE	2020
32026517	Neurocognitive and psychiatric disorders-related axonal degeneration in Parkinson's disease.	Journal of Neuroscience Research	2020
32199095	Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.	Lancet Neurol	2020
31680195	Evaluation of white matter microstructure in patients with Parkinson's disease using microscopic fractional anisotropy.	Neuroradiology	2020
32057166	Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson's disease.	Psychiatry and Clinical Neurosciences	2020
31625432	Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series.	Modern Rheumatology	2020
32105670	NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly.	Journal of Hepatology	2020
32342668	Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.	Liver International	2020
32044685	Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report.	Journal of the Neurological Sciences	2020
31986869	Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure.	Journal of Movement Disorders	2020
32041289	Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan.	Diagnostics	2020
32209994	Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis.	Cancers	2020
32926754	Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study.	Hepatology Research	2020
33086582	The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan.	Diagnostics	2020
32741890	The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals.	Internal Medicine	2020
32570776	Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan.	International Journal of Molecular Sciences	2020
33177546	PPARÎ± agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.	Scientific Reports	2020